Company · CIK 1708331
Virpax Pharmaceuticals, Inc.
| CIK | 1708331 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | PA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-03-31 |
Offerings
7 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-285862 | 2025-03-17 | 2025-03-25 | 2 | |
| 333-284089 | 2024-12-30 | 2025-01-28 | 5 | |
| 333-281080 | 2024-07-29 | 2024-11-13 | 7 | |
| 333-278796 | 2024-04-18 | 2024-05-16 | 6 | |
| 333-267790 | 2022-10-07 | 2022-10-18 | 2 | |
| 333-259421 | 2021-09-09 | 2021-09-15 | 3 | |
| 333-249417 | 2020-10-09 | 2021-02-18 | 7 |
Filings
34| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-03-25 | S-1/AAmendment | 333-285862 | 0001731122-25-000439 |
| 2025-03-17 | S-1Registration filed | 333-285862 | 0001731122-25-000401 |
| 2025-01-28 | 424B4Final prospectus | 333-284089 | 0001731122-25-000131 |
| 2025-01-27 | EFFECTDeclared effective | 333-284089 | 9999999995-25-000203 |
| 2025-01-17 | S-1/AAmendment | 333-284089 | 0001731122-25-000092 |
| 2025-01-15 | S-1/AAmendment | 333-284089 | 0001731122-25-000082 |
| 2024-12-30 | S-1Registration filed | 333-284089 | 0001731122-24-002064 |
| 2024-11-13 | 424B4Final prospectus | 333-281080 | 0001731122-24-001773 |
| 2024-11-12 | EFFECTDeclared effective | 333-281080 | 9999999995-24-003447 |
| 2024-11-07 | S-1/AAmendment | 333-281080 | 0001731122-24-001742 |
| 2024-10-28 | S-1/AAmendment | 333-281080 | 0001731122-24-001662 |
| 2024-10-18 | S-1/AAmendment | 333-281080 | 0001731122-24-001622 |
| 2024-08-13 | S-1/AAmendment | 333-281080 | 0001213900-24-067945 |
| 2024-07-29 | S-1Registration filed | 333-281080 | 0001013762-24-002110 |
| 2024-05-16 | 424B4Final prospectus | 333-278796 | 0001213900-24-044286 |
| 2024-05-14 | EFFECTDeclared effective | 333-278796 | 9999999995-24-001527 |
| 2024-05-13 | S-1/AAmendment | 333-278796 | 0001213900-24-042447 |
| 2024-05-02 | S-1/AAmendment | 333-278796 | 0001213900-24-038733 |
| 2024-04-26 | S-1/AAmendment | 333-278796 | 0001213900-24-036727 |
| 2024-04-18 | S-1Registration filed | 333-278796 | 0001213900-24-034117 |
| 2022-10-18 | EFFECTDeclared effective | 333-267790 | 9999999995-22-003078 |
| 2022-10-07 | S-3Shelf registered | 333-267790 | 0001213900-22-062841 |
| 2021-09-15 | 424B4Final prospectus | 333-259421 | 0001213900-21-048233 |
| 2021-09-14 | EFFECTDeclared effective | 333-259421 | 9999999995-21-003539 |
| 2021-09-09 | S-1Registration filed | 333-259421 | 0001213900-21-047233 |
| 2021-09-01 | DRSDraft made public | 377-05434 | 0001213900-21-045989 |
| 2021-02-18 | 424B4Final prospectus | 333-249417 | 0001213900-21-010341 |
| 2021-02-16 | EFFECTDeclared effective | 333-249417 | 9999999995-21-000649 |
| 2021-02-02 | S-1/AAmendment | 333-249417 | 0001213900-21-005984 |
| 2021-01-08 | S-1/AAmendment | 333-249417 | 0001213900-21-001231 |
| 2020-12-16 | S-1/AAmendment | 333-249417 | 0001213900-20-043072 |
| 2020-11-20 | S-1/AAmendment | 333-249417 | 0001213900-20-038528 |
| 2020-10-09 | S-1Registration filed | 333-249417 | 0001213900-20-030825 |
| 2020-08-10 | DRSDraft made public | 377-03398 | 0001213900-20-021146 |